US8270481091 - Common Stock

We assign a fundamental rating of **4** out of 10 to **SLGN**. **SLGN** was compared to 23 industry peers in the **Containers & Packaging** industry. **SLGN** has an average financial health and profitability rating. **SLGN** has a valuation in line with the averages, but on the other hand it scores bad on growth.

In the past year **SLGN** was profitable.

Each year in the past 5 years **SLGN** had a positive operating cash flow.

The **Return On Assets** of **SLGN** (**3.66%**) is worse than **60.87%** of its industry peers.

The **Return On Equity** of **SLGN** (**16.06%**) is comparable to the rest of the industry.

With a **Return On Invested Capital** value of **7.96%**, **SLGN** perfoms like the industry average, outperforming **47.83%** of the companies in the same industry.

Measured over the past 3 years, the **Average Return On Invested Capital** for **SLGN** is in line with the industry average of **8.35%**.

The last **Return On Invested Capital** (**7.96%**) for **SLGN** is above the 3 year average (**7.76%**), which is a sign of increasing profitability.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.66% | ||

ROE | 16.06% | ||

ROIC | 7.96% |

ROA(3y)4.67%

ROA(5y)4.56%

ROE(3y)22.48%

ROE(5y)22.36%

ROIC(3y)7.76%

ROIC(5y)8.02%

With a **Operating Margin** value of **10.32%**, **SLGN** perfoms like the industry average, outperforming **56.52%** of the companies in the same industry.

Looking at the **Gross Margin**, with a value of **16.49%**, **SLGN** is doing worse than **82.61%** of the companies in the same industry.

In the last couple of years the **Gross Margin** of **SLGN** has remained more or less at the same level.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 10.32% | ||

PM (TTM) | 4.69% | ||

GM | 16.49% |

OM growth 3Y4.42%

OM growth 5Y2.16%

PM growth 3Y7.19%

PM growth 5Y-4.22%

GM growth 3Y0.93%

GM growth 5Y1.05%

The number of shares outstanding for **SLGN** has been reduced compared to 1 year ago.

The number of shares outstanding for **SLGN** has been reduced compared to 5 years ago.

An Altman-Z score of **2.18** indicates that **SLGN** is not a great score, but indicates only limited risk for bankruptcy at the moment.

With a decent **Altman-Z score** value of **2.18**, **SLGN** is doing good in the industry, outperforming **65.22%** of the companies in the same industry.

The Debt to FCF ratio of **SLGN** is **98.15**, which is on the high side as it means it would take **SLGN**, **98.15** years of fcf income to pay off all of its debts.

A Debt/Equity ratio of **1.86** is on the high side and indicates that **SLGN** has dependencies on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.86 | ||

Debt/FCF | 98.15 | ||

Altman-Z | 2.18 |

ROIC/WACC1.18

WACC6.76%

A Current Ratio of **1.39** indicates that **SLGN** should not have too much problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.39 | ||

Quick Ratio | 0.91 |

The earnings per share for **SLGN** have decreased by **-7.91%** in the last year.

The **Revenue** has been growing by **9.41%** on average over the past years. This is quite good.

EPS 1Y (TTM)-7.91%

EPS 3Y22.68%

EPS 5Y19.34%

EPS growth Q2Q-8.66%

Revenue 1Y (TTM)-4.56%

Revenue growth 3Y12.61%

Revenue growth 5Y9.41%

Revenue growth Q2Q-8.49%

Based on estimates for the next years, **SLGN** will show a small growth in **Earnings Per Share**. The EPS will grow by **2.85%** on average per year.

The **Revenue** is expected to grow by **0.71%** on average over the next years.

EPS Next Y-13.48%

EPS Next 2Y-3.37%

EPS Next 3Y1.06%

EPS Next 5Y2.85%

Revenue Next Year-6.78%

Revenue Next 2Y-2.92%

Revenue Next 3Y-1.04%

Revenue Next 5Y0.71%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

The **Price/Earnings** ratio is **11.72**, which indicates a very decent valuation of **SLGN**.

65.22% of the companies in the same industry are more expensive than **SLGN**, based on the **Price/Earnings** ratio.

With a **Price/Forward Earnings** ratio of **11.42**, the valuation of **SLGN** can be described as very reasonable.

The average S&P500 **Price/Forward Earnings** ratio is at **20.22**. **SLGN** is valued slightly cheaper when compared to this.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 11.72 | ||

Fwd PE | 11.42 |

Compared to the rest of the industry, the **Enterprise Value to EBITDA** ratio of **SLGN** is on the same level as its industry peers.

Based on the **Price/Free Cash Flow** ratio, **SLGN** is valued a bit more expensive than 78.26% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 105.06 | ||

EV/EBITDA | 9.43 |

PEG (NY)N/A

PEG (5Y)0.61

EPS Next 2Y-3.37%

EPS Next 3Y1.06%

Compared to an average industry **Dividend Yield** of **2.95**, **SLGN** has a dividend in line with its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.68% |

On average, the dividend of **SLGN** grows each year by **12.17%**, which is quite nice.

Dividend Growth(5Y)12.17%

Div Incr Years12

Div Non Decr Years12

The dividend of **SLGN** is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.

DP27.02%

EPS Next 2Y-3.37%

EPS Next 3Y1.06%

**SILGAN HOLDINGS INC**

NYSE:SLGN (12/8/2023, 7:16:23 PM)

After market: 42.32 0 (0%)**42.32**

**-0.52 (-1.21%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryContainers & Packaging

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap4.51B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.68% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 11.72 | ||

Fwd PE | 11.42 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)0.61

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.66% | ||

ROE | 16.06% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 10.32% | ||

PM (TTM) | 4.69% | ||

GM | 16.49% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.78

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.86 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.39 | ||

Quick Ratio | 0.91 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-7.91%

EPS 3Y22.68%

EPS 5Y

EPS growth Q2Q

EPS Next Y-13.48%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-4.56%

Revenue growth 3Y12.61%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y